<?xml version="1.0" encoding="UTF-8"?>
<p>
 <bold>2. Phase II Safety and Immunogenicity of Live Attenuated Influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 (H5N2) in healthy Thai volunteers</bold>
</p>
